HealthEquity, Inc. (NASDAQ:HQY) Sees Large Decline in Short Interest

HealthEquity, Inc. (NASDAQ:HQY) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totaling 3,662,098 shares, a decrease of 17.0% from the December 31st total of 4,411,284 shares. Approximately 4.4% of the company’s stock are short sold. Based on an average trading volume of 1,288,427 shares, the short-interest ratio is currently 2.8 days. Based on an average trading volume of 1,288,427 shares, the short-interest ratio is currently 2.8 days. Approximately 4.4% of the company’s stock are short sold.

Insider Buying and Selling at HealthEquity

In other news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 13,959 shares of company stock worth $1,344,957 over the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

Institutional Trading of HealthEquity

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Sivia Capital Partners LLC bought a new position in HealthEquity in the 2nd quarter valued at $306,000. Farther Finance Advisors LLC boosted its holdings in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after acquiring an additional 172 shares during the last quarter. 111 Capital acquired a new stake in HealthEquity in the second quarter worth about $342,000. Abel Hall LLC bought a new stake in HealthEquity during the 2nd quarter worth about $203,000. Finally, Tectonic Advisors LLC acquired a new position in HealthEquity during the 2nd quarter valued at about $3,620,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $2.23 on Monday, hitting $87.90. The stock had a trading volume of 575,749 shares, compared to its average volume of 1,095,213. HealthEquity has a twelve month low of $74.07 and a twelve month high of $116.65. The company has a market capitalization of $7.51 billion, a price-to-earnings ratio of 40.31, a price-to-earnings-growth ratio of 1.24 and a beta of 0.24. The firm’s 50 day moving average price is $92.85 and its 200-day moving average price is $93.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the previous year, the firm earned $0.78 earnings per share. The business’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities research analysts predict that HealthEquity will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the company. JMP Securities set a $122.00 price objective on HealthEquity in a report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 target price on shares of HealthEquity in a research report on Friday, December 5th. Citigroup restated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Barclays began coverage on shares of HealthEquity in a research note on Monday, December 8th. They issued an “overweight” rating and a $118.00 price objective for the company. Finally, Barrington Research reissued an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $119.60.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.